NVAX

Novavax, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$8.76

Price (1 Year)

$12.75 $6.57

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %22.7 / %30
Non-compliant assets / Total market cap %44.7 / %30
Non-compliant revenue / Total income %7.1 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine.

Website

Analysis (Turkish): NVAX Hissesi Caiz mi, Helal mi? Novavax, Inc. Katılım Analizi